Ready-to-Use Parenteral Packaging Components Address Evolving Aseptic Fill/Finish Requirements
Ready-to-use components eliminate the need for component preparation by the drug product manufacturer, enabling them to streamline their processes and focus on their core competencies, such as drug product development and manufacturing.
Drug product and parenteral packaging component manufacturers are continuously evolving in alignment with the advancements in technology and increasing regulatory requirements to better ensure the quality and safety of injectable drug products for patients. The incorporation of barrier technology and flexible fillers and the use of ready-to-use (RTU) packaging components are rapidly gaining adoption as safe and effective solutions for fill/finish processes and container closure systems, respectively.
Read this article from Pharmaceutical Technology’s Biologics and Sterile Drug Manufacturing 2018 eBook.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing
Vol. 42
May 2018
Pages: 44–46
Citation
When referring to this article, please cite it as S. Cote, “Ready-to-Use Parenteral Packaging Components Address Evolving Aseptic Fill/Finish Requirements,” Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2018).
